Allelotype analysis of chemically induced squamous cell carcinomas in F1 hybrids of two inbred mouse strains with different susceptibility to tumor progression

Carcinogenesis

Volumn 21, Issue 7, 2000, Pages 1297-1301

  Stern, Mariana C ^a,b   Benavides, Fernando ^b   Klingelberger, Eric A ^b   Conti, Claudio J ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; MICROSATELLITE DNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 14; CHROMOSOME 16; CHROMOSOME 19; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 9; GENOTYPE; HETEROZYGOSITY LOSS; HYBRID; INBRED STRAIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0033924542     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.297     Document Type: Article

References (55)

1. Lasko, D. and Cavenee, W. (1991) Loss of consitutional heterozygosity in human cancer. Annu. Rev. Genet., 25, 281-314.
2. Wiseman, R.W., Cochran, C, Dietrich, W., Lander, E.S. and Soderkivst, P. (1994) Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc. Natl Acad. Sci. USA. 91, 3759-3763.
3. Aldaz, C.M., Trono, D., Larcher, F., Slaga, T.J. and Conti, C.J. (1989) Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol. Carcinog., 2, 22-26.
4. Bianchi, A.B., Aldaz, C.M. and Conti, C.J. (1990) Non-random duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc. Natl Acad. Sci. USA, 87, 6902-6906.
5. Bianchi, A.B., Navone, N., Aldaz, C.M. and Conti, C.J. (1991) Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis. Proc. Natl Acad. Sci. USA, 88, 7590-7594.
6. Kemp, C.J., Fee, F. and Balmain, A. (1993) Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential alterations on chromosomes 6, 7 and 11. Cancer Res., 53, 6022-6027.
7. Zenklusen, J., Hodges, L. and Conti, C. (1997) Loss of heterozygosity on murine chromosome 6 in two-stage carcinogenesis: evidence for a conserved tumor suppressor gene. Oncogene, 14, 109-114.
8. Gimenez-Conti, I.B., Bianchi, A.B., Fischer, S.M., Reiners, J.J., Conti, C.J. and Slaga, T.J. (1992) Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res., 52, 3432-3435.
9. Stern, M.C., Gimenez-Conti, I.B. and Conti, C.J. (1995) Genetic susceptibility to papilloma progression in the SENCAR mice. Carcinogenesis, 16, 1947-1953.
10. Stern, M.C., Gimenez-Conti, I.B., Budunova, I., Coghlan, L., Fischer, S.M., DiGiovanni, J., Slaga, T.J. and Conti, C.J. (1998) Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression. Carcinogenesis, 19, 125-132.
11. Stern, M.C., Duran, H.A., McKenna, E.A.V. and Conti, C.J. (1997) Increased apoptosis during papilloma development in mice susceptible to tumor progression. Mol. Carcinog., 20, 137-142.
12. Fischer, S.M., O'Connell, J.F., Conti, C.J., Tacker, K.C., Fries, J.W., Patrick, K.E., Adams, L.M. and Slaga, T.J. (1987) Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis, 8, 421-424.
13. Hennings, H., Lowry, D.T., Yuspa, S.H., Mock, B. and Potter, M. (1997) New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas. Mol. Carcinog., 20, 143-150.
14. Aldaz, C.M., Conti, C.J., Klein-Szanto, A.J.P. and Slaga, T.J. (1987) Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc. Natl Acad. Sci. USA. 84, 2029-2032.
15. Oshimura, M., Kugoh, H., Koi, M., Shimizu, M., Yamada, H., Satoh, H. and Barrett, C.J. (1990) Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J. Cell Biol., 42, 135-142.
16. Saxon, P.J., Srivatsan, E.S. and Stanbridge, E.J. (1986) Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. Eur. J. Mol. Biol., 5, 3461-3466.
17. Weissman, B.E., Saxon, P.J., Pasquale, S.R., Jones, G.R., Geiser, A.G. and Stanbridge, E.J. (1987) Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science, 236, 175-180.
18. Gioeli, D., Conway, K. and Weissman, B. (1997) Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures. Cancer Res., 57, 1157-1165.
19. Zenklusen, J.C., Oshimura, M., Barrett, J.C. and Conti, C.J. (1995) Human chromosome 11 inhibits tumorigenicity of a murine squamous cell carcinoma cell line. Genes Chromosom. Cancer, 13, 47-53.
20. Akervall, J., Jin, Y., Wennerberg, J., Zatterstrom, U., Kjellen, E., Mertens, F., Willen, R., Mandahl, N., Heim, S. and Mitelman, F. (1995) Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer, 76, 853-859.
21. Parangi, S., Dietrich, W., Christofori, G., Lander, E. and Hanahan, D. (1995) Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Res., 55, 6071-6076.
22. Quinn, A., Sikkink, S. and Rees, J. (1994) Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res., 54, 4756-4759.
23. Aldaz, C.M., Liao, Q.Y., Paladugu, A., Rehm, S. and Wang, H. (1996) Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Mol. Carcinog., 17, 126-133.
24. Hegi, M.E., Devereux, T.R., Dietrich, W.F., Cochran, C.J., Lander, E.S., Foley, J.F., Maronpot, R.R., Anderson, M.W. and Wiseman, R.W. (1994) Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res., 54, 6257-6264.
25. Herzog, C., Wang, Y. and You, M. (1995) Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene, 11, 1811-1815.
26. Maestro, R., Gasparotto, D., Vukosavljevic, T., Barzan, L., Sulfaro, S. and Boiocchi, M. (1993) Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res., 53, 5775-5779.
27. Maher, E.R., Bentley, E., Yates, J.R., Latif, F., Lerman, M., Zbar, B., Affara, N.A. and Ferguson-Smith, M.A. (1991) Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. Genomics, 10, 957-960.
28. Bepler, G. and Garcia-Blanco, M. (1994) Three tumor-suppressor regions on chromosome lip identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc. Natl Acad. Sci. USA, 91, 5513-5517.
29. Theillet, C., Lidereau, R., Escot, C., Hutzell, P., Brunet, M., Gest, J., Schlom, J. and Callahan, R. (1986) Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res., 46, 4776-4781.
30. Scrable, H., Witte, D., Lampkin, B. and Cavenee, W. (1987) Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature, 329, 645-647.
31. Wadey, R., Pal, N., Buckle, B., Yeomans, E., Pritchard, J. and Cowell, J. (1990) Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene, 5, 901-907.
32. Fearon, E., Feinberg, A., Hamilton, S. and Vogelstein, B. (1985) Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature, 318, 377-380.
33. Radice, P., Pierotti, M., Lacerenza, S., Mondini, P., Radice, M., Pilotti, S. and Della, P.G. (1989) Loss of heterozygosity in human germinal tumors. Cytogenet. Cell Genet., 52, 72-76.
34. Uzawa, K., Suzuki, H., Komiya, A., Nakanishi, H., Ogawara, K., Tanzawa, H. and Sato, K. (1996) Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int. J. Cancer, 67, 510-514.
35. Negrini, M., Rasio, D., Hampton, G.M., Sabbioni, S., Rattan, S., Carter, S.L., Rosenberg, A.L., Schwartz, G.F., Shiloh, Y., Cavenee, W.K. and Croce, C.M. (1995) Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res., 55, 3003-3007.
36. Hampton, G.M., Penny, L.A., Baergen, R.N., Larson, A., Brewer, C., Liao, S., Busby-Earle, R.M.C., Williams, A.W.R., Steel, C.M., Bird, C.C., Stanbridge, E.J. and Evans, G.A. (1994) Loss of heterozygosity in cervical carcinomal subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-24. Proc. Natl Acad. Sci. USA, 91, 6953-6957.
37. Gustafson, C.E., Young, J., Leggett, B., Searle, J. and Chenevix-Trench, G. (1994) Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumors. Br. J. Cancer, 70, 395-397.
38. Gabra, H., Taylor, L., Cohen, B.B., Lessels, A., Eccles, D.M., Leonald, R.C.F., Smyth, J.F. and Steel, C.M. (1995) Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br. J. Cancer, 72, 367-375.
39. Herbst, R.A., Larson, A., Weiss, J., Cavenee, W.K., Hampton, G.M. and Arden, K.C. (1995) A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res., 55, 2494-2496.
40. Yamakawa, K., Morita, R., Takahashi, E., Hori, T.I., Shikawa, J. and Nakamura, Y. (1991) A detailed mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res., 51, 4707-4711.
41. Loughran, O., Clark, L., Bond, J., Baker, A., Berry, L., Edington, K., Ly, I., Simmons, R., Haw, R., Black, D., Newbold, R. and Parkinson, E. (1997) Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene, 14, 1955-1964.
42. Englefield, P., Foulkes, W.D. and Campbell, I.G. (1994) Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Br. J. Cancer, 70, 905-907.
43. Harada, T., Irving, R.M, Xuereb, J.H., Barton, D.E., Hardy, D.G., Moffat, D.A. and Maher, E.R. (1996) Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. J. Neurosurg., 84, 847-851.
44. Shin, E., Fujita, S., Takami, K., Kurahashi, H., Kurita, Y., Kobayashi, T., Mori, T., Nishisho, I. and Takai, S. (1993) Deletion mapping of chromosome Ip and 22q in pheochromocytoma. Jpn J. Cancer Res., 84, 402-408.
45. Yana, I., Kurahashi, H., Nakamori, S., Kameyama, M., Nakamura, T., Takami, M., Mori, T., Takai, S. and Nishisho, I. (1995) Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int. J. Cancer, 60, 174-177.
46. Schofield, D.E., Beckwith, J.B. and Sklar, J. (1996) Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosom. Cancer, 15, 10-17.
47. Crundwell, M.C., Chughtai, S., Knowles, M., Takle, L., Luscombe, M., Neoptolemos, J.P., Morton, D.G. and Phillips, S.M. (1996) Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer. Int. J. Cancer, 69, 295-300.
48. Menon, A.G., Rutter, J.L., von Sattel, J.P., Synder, H., Murdoch, C., Blumenfeld, A., Martuza, R.L., von Deimling, A., Gusella, J.F. and Houseal, T.W. (1997) Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Oncogene, 14, 611-616.
49. Herbers, J., Schullerus, D., Muller, H., Kenck, C., Chudek, J., Weimer, J., Bugert, P. and Kovacs, G. (1997) Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosom. Cancer, 19, 29-35.
50. Koike, M., Chumakov, A.M., Takeuchi, S., Tasaka, T., Yang, R., Nakamaki, T., Tsuruoka, N. and Koeffler, H.P. (1997) C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia. Leukemia Res., 21, 833-839.
51. Lukeis, R., Irving, L., Garson, M. and Hasthorpe, S. (1990) Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities. Genes Chromosom. Cancer, 2, 116-124.
52. Shimada, M., Ohtsuka, E., Shimizu, T., Matsumoto, T., Matsushita, K., Tanimoto, F. and Kajii, T. (1997) A recurrent translocation, t(16;2l)(q24; q22), associated with acute myelogenous leukemia: identification by fluorescence in situ hybridization. Cancer Genet. Cytogenet., 96, 102-105.
53. Babu, V.R., Miles, B.J., Cerney, J.C., Weiss, L. and van Dyke, D.L. (1989) Chromosome 21q22 deletion. A specific chromosome change in a new bladder cancer subgroup. Cancer Genet. Cytogenet., 38, 127-129.
54. Chan, A.S., Lam, W.K., Wong, M.P., Fu, K.H., Lee, J., Yew, W.W., Chiu, S.W. and Lung, M.L. (1996) Chromosomal 11 alterations in non-small-cell lung carcinomas in Hong Kong. Lung Cancer, 15, 51-65.
55. Falchetti, A., Morelli, A., Amorosi, A., Tonelli, F., Fabiani, S., Martineti, V., Castello, R., Furlani, L. and Brandi, M.L. (1997) Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab., 82, 2278-2282.